The launch of NCRI’s Cellular Molecular Pathology initiative (CM-Path) took place on 6 June. Funders, NCRI Partners, consumers and CM-Path members came together to set a strategy for the next five years. Plans developed on the day by each of the initiative’s four workstreams will now be reviewed by the CM-Path Executive Group and, following approval, CM-Path members will begin to implement their strategies. Further information will be available soon. In the meantime you can view the highlights of the day on our latest Storify feed.